Pharma set for prosperous 2018 as 44,500 attend CPhI Worldwide

21 Nov 2017

Germany tops quality-ranking categories in the inaugural CPhI Global Pharma Index.

CPhI Worldwide, organised by UBM, closes its 28th edition with pre-audit figures indicating a record-breaking attendance of over 44,500 and 2,598 exhibitors. Held in Frankfurt (Germany), the heart of Europe’s biggest pharmaceutical market (24-26 October 2017), the world’s largest pharma event saw attendees from 169 countries, 25% of which are CEO or board level.

Pharma set for prosperous 2018 as 44,500 attend CPhI Worldwide

CPhI Worldwide is widely used as a barometer of pharma’s overall health, as it is the only platform that brings together global pharma, and a strong event is reflective of a prosperous pharma industry. Over 85% of attendance is international, with over 6,000 people travelling from China and India alone. In fact, 71% of all visitors have purchasing power, with an average annual budget of EUR 3.5 million per department.

Remarkably, in just the last 3 years, CPhI Worldwide has grown its audience base by a staggering 10,000 people, pulling in new attendees from across finished formulations and biologicals – with the latter set to see further growth with the launch of a new event, BioLive in 2018.

UBM attributes the impressive increase in attendance to its enhanced reputation as a meeting ground for pharma businesses – the event recorded over 56,598 company searches and 952,152 interactions though its supplier finder tools – and its commitment to introducing the latest technological advances that make CPhI Worldwide easier to navigate; for example, there were more than 9,000 downloads of its mobile app (up 80% year-on-year) and a rise in social media engagement.

In another ground-breaking achievement, the 2017 event saw the launch of the world’s first ever reputation league table of major pharma industries – the CPhI Global Pharma Index – which scores the reputes of the major pharma economies across a range of attributes. Aptly, Germany – the host country – finished top of the rankings for pharmaceutical quality in both ‘APIs’ and ‘finished dosage drugs’. Germany was also voted by the industry as the best country for both ‘knowledge of its pharma professionals’ and ‘transparency index’ – essentially, a rank of countries with the best regulations, business transparency and anti-corruption practices. Highlighting the industry’s confidence, of the 500 pharma companies surveyed in the CPhI Global Pharma Index, nearly 80% of respondents were either ‘confident’ or ‘extremely confident’ (60%) in their business outlook for 2018, and 84% of companies stated they are actively looking for new international partners.

Another major factor in the event’s continued success is its zonal layout, with outsourcing, machinery, and packaging represented by co-located ICSE, P-MEC, and Innopack, respectively. In total, CPhI Worldwide featured 22 country pavilions and 19 different zones covering the entire supply chain, with bio exhibitors becoming increasingly prominent.

Finally, in the celebration of the global pharmaceutical industry, the CPhI Pharma Awards also experienced a bumper year, doubling the number of entries and finalists – with more than 200 submissions and 19 innovative winners.

"CPhI Worldwide continues to lead the way for pharma globally, and the event is fundamental to how our global industry meets new partners, learns about the latest trends and does the deals driving forward drug development and commercial production. With a record-breaking event and nearly 44,500 attendees, 2018 looks set to be another stellar year for pharma. But it’s also going to be a huge year for UBM, as we expand our reach into the MENA region – with CPhI MEA – and introduce a dedicated bio processing event, BioLive, to run parallel to CPhI next year in Madrid,” said Orhan Caglayan, Brand Director Europe, UBM EMEA.

Read More

Related news

The game is on for connected devices

The game is on for connected devices

20 Feb 2020

Global biologics markets, delivery device innovation and smart packaging ‘unpacking’ new growth opportunities for pharma.

Read more 
CPhI South East Asia rescheduled for July 2020

CPhI South East Asia rescheduled for July 2020

18 Feb 2020

Event move ensures extra precautions and safety measures taken

Read more 
Report predicts booming ASEAN generics export market for 2020

Report predicts booming ASEAN generics export market for 2020

13 Feb 2020

The changing opportunities are attributed to rising GMP standards and increased regional harmonization.

Read more 
Innovation awarded at Pharmapack

Innovation awarded at Pharmapack

10 Feb 2020

Innovations across primary and secondary packaging, drug delivery devices, and machinery acknowledged in Exhibitor Innovations, with Health Product Awards for patient-centricity and eco-design.

Read more 
Digital value-added medicines - a key driver for 2020

Digital value-added medicines - a key driver for 2020

29 Jan 2020

Pharmapack also identifies waste management and the use of blockchain as key trends for the year ahead.

Read more 
CPhI and AAPS partner to expand expert scientific content at CPhI North America

CPhI and AAPS partner to expand expert scientific content at CPhI North America

10 Jan 2020

CPhI and the American Association of Pharmaceutical Scientists (AAPS) today announced a partnership to expand the scientific content of activities sponsored by CPhI, including CPhI North America—the only event to bring the entire North American pharmac...

Read more 
Innovation and regulatory harmonisation to drive Indian pharma in 2020

Innovation and regulatory harmonisation to drive Indian pharma in 2020

18 Dec 2019

Experts suggest the continued goal of aligning India to Western regulatory standards will help the country sustain significant increases in exports.

Read more 
Connectivity, customization and sustainability driving packaging and drug delivery in 2020

Connectivity, customization and sustainability driving packaging and drug delivery in 2020

4 Dec 2019

Pharmapack 2020 gathering top specialists and pioneers to exchange their vision on best strategies to tackle key challenges.

Read more 
Worldwide event predicts global pharma trends for 2020

Worldwide event predicts global pharma trends for 2020

27 Nov 2019

Content sessions identify value-added medicines, preventive drugs, early diagnostics and patient experience as some of the trends for the year ahead.

Read more 
India pharma forecast to grow strongly in 2020

India pharma forecast to grow strongly in 2020

22 Nov 2019

The rise in exports growth potential is believed to be in response to concerted reforms by the CDSCO and industry quality improvements in the last few years.

Read more